The minimum inhibitory concentrations (MIC) of a series of synthetic inert polypyridylruthenium(II) complexes against four strains of bacteria--Gram positive Staphylococcus aureus (S. aureus) and methicillin-resistant S. aureus (MRSA), and Gram negative Escherichia coli (E. coli) and Pseudomonas aeruginosa (P. aeruginosa)--have been determined. The results demonstrate that for the dinuclear ruthenium(II) complexes ΔΔ/ΛΛ-[{Ru(phen)(2)}(2){μ-bb(n)}](4+) {where phen = 1,10-phenanthroline; bb(n) = bis[4(4'-methyl-2,2'-bipyridyl)]-1,n-alkane (n = 2, 5, 7, 10, 12 or 16)} the complexes linked by the bb(12), bb(14) and bb(16) ligands are highly active, with MIC values of 1 μg mL(-1) against both S. aureus and MRSA, and 2-4 and 8-16 μg mL(-1) against E. coli and P. aeruginosa, respectively. The mononuclear complex [Ru(Me(4)phen)(3)](2+) showed equal activity (on a mole basis) against S. aureus compared with the Rubb(12), Rubb(14) and Rubb(16), but was considerably less active against MRSA and the two Gram negative bacteria. For the dinuclear Rubb(n) family of complexes, the antimicrobial activity was related to the octanol-water partition coefficient (logP). However, the highly lipophilic mononuclear complex Δ-[Ru(phen)(2)(bb(16))](2+) was significantly less active than Rubb(16), highlighting the importance of the dinuclear structure. Preliminary toxicity assays were also carried out for the ΔΔ isomers of Rubb(7), Rubb(10), Rubb(12) and Rubb(16) against two human cells lines, fresh red blood cells and THP-1 cells. The results showed that the dinuclear ruthenium complexes are significantly less toxic to human cells compared to bacterial cells, with the HC(50) and IC(50) values 100-fold higher than the MIC for the complex that showed the best potential--ΔΔ-Rubb(12).

A detailed investigation of a valence tautomeric (VT) transition for the new complex [Co(III)(3,5-DBCat)(3,5-DBSQ)(py)₂]/[Co(II)(3,5-DBSQ)₂(py)₂] (1) is reported, where 3,5-DBCatH₂ is 3,5-di-tert-butyl-catechol, 3,5-DBSQH is 3,5-di-tert-butyl-semiquinone and py is pyridine. Complex 1 exists as a mixture of the two valence tautomers, with the relative proportion of each depending on the external conditions. Three differently solvated forms of the complex have been synthesized and variable temperature structural and magnetic investigations of one of these, 1·0.5py, reveals that this compound undergoes a thermally-induced VT transition from the [Co(III)(3,5-DBCat)(3,5-DBSQ)(py)₂] tautomer at temperatures below 150 K to a 1 : 1 mixture of the two tautomers at temperatures above 300 K. The VT transition may also be photo-induced at 9 K, affording a similar mixture of the two tautomers. In both cases the incomplete transition is attributed to the presence of π-π stacking interactions between the pyridine molecules of solvation and one of the two crystallographically independent complex molecules, which inhibits the expansion of this molecule that would accompany a VT transition. Studies on alternatively solvated forms 1·2MeCN and 1·1.67hexane also suggest a significant dependence of the VT transition on solvation-induced packing effects and/or intermolecular interactions.

A series of polypyridyl-ruthenium(II) and -iridium(III) complexes that contain labile chlorido ligands, [{M(tpy)Cl}(2){μ-bb(n)}](2/4+) {Cl-Mbb(n); where M = Ru or Ir; tpy = 2,2':6',2''-terpyridine; and bb(n) = bis[4(4'-methyl-2,2'-bipyridyl)]-1,n-alkane (n = 7, 12 or 16)} have been synthesised and their potential as antimicrobial agents examined. The minimum inhibitory concentrations (MIC) and minimum bactericidal concentrations (MBC) of the series of metal complexes against four strains of bacteria - Gram positive Staphylococcus aureus (S. aureus) and methicillin-resistant S. aureus (MRSA), and Gram negative Escherichia coli (E. coli) and Pseudomonas aeruginosa (P. aeruginosa) - have been determined. All the ruthenium complexes were highly active and bactericidal. In particular, the Cl-Rubb(12) complex showed excellent activity against all bacterial cell lines with MIC values of 1 μg mL(-1) against the Gram positive bacteria and 2 and 8 μg mL(-1) against E. coli and P. aeruginosa, respectively. The corresponding iridium(III) complexes also showed significant antimicrobial activity in terms of MIC values; however and surprisingly, the iridium complexes were bacteriostatic rather than bactericidal. The inert iridium(III) complex, [{Ir(phen)(2)}(2){μ-bb(12)}](6+) {where phen = 1,10-phenanthroline) exhibited no antimicrobial activity, suggesting that it could not cross the bacterial membrane. The mononuclear model complex, [Ir(tpy)(Me(2)bpy)Cl]Cl(2) (where Me(2)bpy = 4,4'-dimethyl-2,2'-bipyridine), was found to aquate very rapidly, with the pK(a) of the iridium-bound water in the corresponding aqua complex determined to be 6.0. This suggests the dinuclear complexes [Ir(tpy)Cl}(2){μ-bb(n)}](4+) aquate and deprotonate rapidly and enter the bacterial cells as 4+ charged hydroxo species.

The inert dinuclear ruthenium(II) complexes Rubb(12) and Rubb(16) have potential as new antimicrobial agents. The structure of the dinuclear ruthenium complexes can be readily further modified in order to increase their selectivity for bacteria over human cells.

The accumulation, uptake mechanism, cytotoxicity, cellular localisation of-and mode of cell death induced by-dinuclear ruthenium(II) complexes ΔΔ/ΛΛ-[{Ru(phen)(2) }(2) {μ-bb(n) }](4+) (Rubb(n)), where phen is 1,10-phenanthroline, bb(n) is bis[4(4'-methyl-2,2'-bipyridyl)]-1,n-alkane (n=2, 5, 7, 10, 12 or 16), and the corresponding mononuclear complexes containing the bb(n) ligands, were studied in L1210 murine leukaemia cells. Cytotoxicity increased with linker chain length, and the ΔΔ-Rubb(16) complex displayed the highest cytotoxicity of the series, with an IC(50) value of 5 μM, similar to that of carboplatin in the L1210 murine leukaemia cell line. Confocal microscopy and flow cytometry studies indicated that the complexes accumulate in the mitochondria of L1210 cells, with the magnitude of cellular uptake and accumulation increasing with linking chain length in the bb(n) bridge of the metal complex. ΔΔ-Rubb(16) entered the L1210 cells by passive diffusion (with a minor contribution from protein-mediated active transport), inducing cell death via apoptosis. Additionally, metal-complex uptake in leukaemia cells was approximately 16-times that observed in healthy B cells highlighting that the bb(n) series of complexes may have potential as selective anticancer drugs.

The paper reports the synthesis and characterisation of a series of flexible di-bidentate bridging ligands in which two 4-methyl-2,2'-bipyridine groups are linked at the 4'-position by polymethylene (bb(n)), linear polyether (bbO(n)) or linear alkylamine (bbN(n)) chains of varying length (n). The enantiomers (ΔΔ/ΛΛ) of the rac forms of the ruthenium(ii) dinuclear complexes incorporating these ligands -i.e. [{Ru(phen)(2)}(2)(μ-BL)](4+) (phen = 1,10-phenanthroline; BL = bb(n), bbO(n) or bbN(n)) - have been isolated by reaction of Δ- or Λ-[Ru(phen)(2)(py)(2)](2+) (py = pyridine) with the respective bridging ligands. Mononuclear species - in which only one of the bidentate moieties of the bridging ligand is coordinated - have also been isolated, as well as trinuclear and tetranuclear species involving the bb(7) bridge. Fluorescence displacement studies of the DNA-binding of the dinuclear complexes containing the bbO(n) and bbN(n) bridges generally revealed a lower affinity than their bb(n) analogues for an oligonucleotide containing a single bulge site; the mononuclear complexes showed a lower affinity - and the trinuclear and tetranuclear complexes a higher affinity - than the dinuclear species, revealing an interesting interplay of lipophilicity, electrostatics and size in the complex/nucleic acid interaction. Cytotoxicity studies of these complexes against a murine leukaemia cell line revealed that the presence of the polyether or polyamine links in the chain lowered the cytotoxicity compared with their polymethylene analogues, and that the bb(7)-bridged trinuclear and tetranuclear complexes showed considerably enhanced cytotoxicity compared with the dinuclear Rubb(7) analogue.

No abstract

Seven new di-, tri-, tetra-, and hexanuclear iron complexes that incorporate a polydentate Schiff base and variously substituted catecholate ligands have been synthesized from the trinuclear precursor [Fe(3)(OAc)(3)(L)(3)] (1), where LH(2) = 2-[[(2-hydroxyethyl)imino]phenylmethyl]-phenol. These were isolated as the compounds [Fe(3)(OAc)(Cat)(L)(3)] (2), [Fe(6)(OAc)(2)(Cat)(4)(L)(4)] (3), [Fe(4)(3,5-DBCat)(2)(L)(4)] (4), [Bu(4)N][Fe(4)(OAc)(3,5-DBCat)(4)(L)(2)] (5a, 5(-) is the complex monoanion [Fe(4)(OAc)(3,5-DBCat)(4)(L)(2)](-)), [Fe(4)(OAc)(3,5-DBCat)(3)(3,5-DBSQ)(L)(2)] (6), [Fe(2)(Cl(4)Cat)(2)(L)(LH(2))(H(2)O)] (7), and [Et(3)NH](2)[Fe(2)(Cl(4)Cat)(2)(L)(2)] (8a, 8(2-) is the complex dianion [Fe(2)(Cl(4)Cat)(2)(L)(2)](2-)), where CatH(2) = catechol; 3,5-DBCatH(2) = 3,5-di-tert-butyl-catechol; 3,5-DBSQH = 3,5-di-tert-butyl-semiquinone, and Cl(4)CatH(2) = tetrachlorocatechol. While compounds 2-4, 5a, 7, and 8a were obtained by directly treating 1 with the appropriate catechol, compound 6 was synthesized by chemical oxidation of 5a. These compounds have been characterized by single crystal X-ray diffraction, infrared and UV-visible spectroscopy, voltammetry, UV-visible spectroelectrochemistry, and magnetic susceptibility and magnetization measurements. An electrochemical study of the three tetranuclear complexes (4, 5(-), and 6) reveals multiple reversible redox processes due to the o-dioxolene ligands, in addition to reductive processes corresponding to the reduction of the iron(III) centers to iron(II). A voltammetric study of the progress of the chemical oxidation of compound 5a, together with a spectroelectrochemical study of the analogous electrochemical oxidation, indicates that there are two isomeric forms of the one-electron oxidized product. A relatively short-lived neutral species (5) that possesses the same ligand arrangement as complex 5(-) is the kinetic product of both chemical and electrochemical oxidation. After several hours, this species undergoes a significant structural rearrangement to convert to complex 6, which appears to be largely driven by the preference for the 3,5-DBSQ(-) ligand to bind in a non-bridging mode. Variable temperature magnetic susceptibility measurements for compounds 3, 4, 5a, 6, 7, and 8a reveal behavior dominated by pairwise antiferromagnetic exchange interactions, giving rise to a poorly isolated S = 0 ground state spin for compound 3, well-isolated S = 0 ground state spins for complexes 4, 5(-), 7 and 8(2-), and a well-isolated S = 1/2 ground state spin for complex 6. The ground state spin values were confirmed by low temperature variable field magnetization measurements. The thermal variation of the magnetic susceptibility for compounds 3, 4, 5a, 6, 7, and 8a were fitted and/or simulated using the appropriate Hamiltonians to derive J values that are consistent with magnetostructural correlations that have been reported previously for alkoxo-bridged ferric complexes.